Signature of seven cuproptosis-related lncRNAs as a novel biomarker to predict prognosis and therapeutic response in cervical cancer.

Liu, Xinyu; Zhou, Lei; Gao, Minghui; Dong, Shuhong; Hu, Yanan; Hu, Chunjie

Liu, Xinyu; Zhou, Lei; Gao, Minghui; Dong, Shuhong; Hu, Yanan; Hu, Chunjie.

Afiliação

Liu X; Department of Obstetrics and Gynecology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
Zhou L; NHC Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy, Harbin Medical University, Harbin, China.
Gao M; Department of Orthopedics, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Dong S; Department of Obstetrics and Gynecology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
Hu Y; NHC Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy, Harbin Medical University, Harbin, China.
Hu C; Department of Obstetrics and Gynecology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.

Front Genet ; 13: 989646, 2022.

Article em En | MEDLINE | ID: mdl-36204323

Palavras-chave

cervical cancer; cuproptosis; immunotherapy; lncRNA; prognosis; targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Genet Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google